FIELD: biochemistry.
SUBSTANCE: invention relates to neutral lipopolymer of formula 1 , wherein R1 and R2 independently are alkyl or alkenyl C8-C24-chain; n = 10-300; Z is selected from group consisting of hydroxyl, alkoxyl, benzyloxy, carboxyl acid ester, sulfonic acid ester, alkyl or aryl carbonate, amino, and alkylamino; L is selected from group comprising: (i) X-(C=O)-Y-CH2-, (ii) -X-(C=O)-, and (iii) -X-CH2-, wherein X and Y independently are oxygen, NH and direct bond with the proviso, that when L is -X-(C=O)-, X is not NH. Liposomal composition and method for prolongation of liposome circulating time also are disclosed.
EFFECT: neutral lipopolymer providing elongation of liposome circulating time.
11 cl, 5 ex, 6 tbl, 10 dwg
Title | Year | Author | Number |
---|---|---|---|
NEW THERMALLY-SENSITIVE LIPOSOMES CONTAINING THERAPEUTIC AGENTS | 2008 |
|
RU2497499C2 |
STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2732567C2 |
PEGYLATED LIPOSOMES AND THEIR APPLICATION METHODS | 2017 |
|
RU2796539C2 |
LIPOSOMAL COMPOSITION FOR APPLICATION IN PERITONEAL DIALYSIS | 2013 |
|
RU2609860C2 |
PHARMACEUTICAL COMPOSITIONS OF PEGYLATED LIPOSOMES AND COAGULATION FACTORS | 2015 |
|
RU2737291C2 |
COMPOUNDS BASED ON PLATINUM AND LIPIDS AND NANOPARTICLES | 2014 |
|
RU2737735C2 |
LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES | 2014 |
|
RU2679896C2 |
NEW LIPOSOME COMPOSITIONS | 2006 |
|
RU2454229C2 |
NUCLEIC ACID DELIVERY SYSTEM | 2002 |
|
RU2294192C2 |
PEGYLATED COMPOUNDS OF RECOMBINANT HUMAN GROWTH HORMONE | 2009 |
|
RU2530714C9 |
Authors
Dates
2005-04-27—Published
2000-07-12—Filed